GSK256066

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for GSK256066, covering 2012-06-04 to 2017-08-21. Get the full timeline:

Most recent: Clinical Trial Update: A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis [Phase 2]